Molecular Partners AG
MOLN
$3.80
-$0.09-2.31%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -100.00% | -72.63% | 271.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -100.00% | -72.63% | 271.50% |
| Cost of Revenue | -10.32% | -17.80% | -20.01% | -4.42% | 11.84% |
| Gross Profit | -1.74% | -2.01% | 12.42% | -14.69% | -2.23% |
| SG&A Expenses | -1.39% | -8.61% | -6.60% | 1.72% | -5.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.06% | -15.58% | -15.63% | -2.73% | 6.90% |
| Operating Income | -0.87% | 1.00% | 10.40% | -10.44% | 0.01% |
| Income Before Tax | -48.26% | -44.04% | 42.75% | -46.43% | 6.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -48.26% | -44.03% | 42.74% | -46.43% | 6.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.26% | -44.03% | 42.74% | -46.43% | 6.22% |
| EBIT | -0.87% | 1.00% | 10.40% | -10.44% | 0.01% |
| EBITDA | -0.88% | 0.59% | 10.65% | -10.93% | -0.02% |
| EPS Basic | -31.58% | -28.37% | 48.99% | -44.88% | 7.22% |
| Normalized Basic EPS | -14.71% | -28.38% | 49.00% | -44.87% | 7.24% |
| EPS Diluted | -31.58% | -28.37% | 48.68% | -44.88% | 7.22% |
| Normalized Diluted EPS | -14.71% | -28.38% | 49.00% | -44.87% | 7.24% |
| Average Basic Shares Outstanding | 12.69% | 12.19% | 12.26% | 1.09% | 1.07% |
| Average Diluted Shares Outstanding | 12.69% | 12.19% | 12.26% | 1.09% | 1.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |